Kinex Pharmaceuticals Management

About Us Team Pipeline News Contact Us Careers Home
Kinex Named to Science Coalition List

Kinex to Present at the 101st Annual AACR Meeting

Kinex Technology Highlighted at American Chemical Society Symposium

Charles E. Lannon Appointed as Vice-Chairman of the Board at Kinex Pharmaceuticals

Kinex Pharmaceuticals Initiates a Phase 2 Clinical Trial of KX2-391 in Patients with Prostate Cancer

More headlines ...

Management Team


David Hangauer, Ph.D.
Senior Vice President
Research & Development
dhangauer@kinexpharma.com

Dr. Hangauer is a leader in the field of structure based drug design. Following graduate studies at the University at Buffalo, he spent ten years at Merck Sharp and Dohme Research Laboratories where he directed a variety of drug discovery projects. In 1989, Dr. Hangauer returned to academia and joined the chemistry faculty at SUNY Buffalo where he has had a productive career that has focused on developing protein kinase inhibitors.

Dr. Hangauer's expertise is highly sought by pharmaceutical and biotechnology companies worldwide, underscoring his level of expertise and his recognition as a major contributor to commercial drug discovery efforts.